Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance). - Dercle L; Geyer S; Nixon AB; Innocenti F; Shi Q; Jacobson SB; Luk L; Liu A; Yang H; Wen Y; Zhao B; Eche T; et al. (ESMO open, 2025)